This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $39,380.18 firm fixed-price delivery order is for the supply of 4566708161 - KEYTRUDA 100 MG/4 ML VIAL 4ML, with a completion date of January 2, 2025.
DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract supports the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The current award is not associated with a set-aside designation.
Generated 3/11/25, 9:42 AM